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The Vpu protein of human immunodeficiency virus type 1 (HIV-1) has been reported to enhance virion release from infected
cells and to down-regulate the expression of CD4 on infected cells. Previous studies have shown that Vpu and the envelope
glycoprotein precursor (gp160) are translated from different reading frames of the same bicistronic messenger RNA (mRNA).
In order to assess the effect of the Vpu sequences 5 to the Env open reading frame on Env biosynthesis and pathogenesis,
we have constructed a deletion mutant of a molecularly cloned chimeric simian–human immunodeficiency virus (SHIVKU-1bMC33)
in which the entire coding region of vpu upstream of env had been deleted (novpuSHIVKU-1bMC33). While both SHIVKU-1bMC33 and
novpuSHIVKU-1bMC33 synthesized comparable amounts of env mRNA in infected cells, the novpuSHIVKU-1bMC33-infected cells
synthesized more Env precursor when standardized against the p57 Gag precursor protein. While more Env was synthesized
than Gag in novpuSHIVKU-1bMC33-infected cells, pulse–chase analysis revealed that p27 Gag protein was released from infected
cells with delayed kinetics, a reflection of the lack of a Vpu protein. Inoculation of novpuSHIVKU-1bMC33 into two pig-tailed
macaques resulted in no loss of circulating CD4 T cells. However, replicating virus could be detected in the lymphoid tissues
(lymph nodes, spleen, thymus) 1 year after inoculation and the thymus of one of the macaques exhibited severe atrophy. TheINTRODUCTION
Of the known lentiviruses, human immunodeficiency
virus type 1 (HIV-1) and simian immunodeficiency virus of
chimpanzees (SIVcpz) are the only ones that code for a
Vpu protein (Strebel et al., 1988; Huet et al., 1990; Gao et
al., 1998). Vpu is a type I membrane-bound protein with
an uncleaved signal sequence whose cytoplasmic do-
main is phosphorylated by casein kinase II at two serine
residues and is localized in the rough endoplasmic re-
ticulum/Golgi complex of infected cells (Maldarelli et al.,
1993; Schubert et al., 1994). While expression of Vpu
protein is dispensable for HIV-1 replication in vitro, stud-
ies have shown that Vpu enhances virion release from
infected cells, down-regulates CD4 from the surface of
infected cells through degradation via the proteasome
pathway, and enhances syncytia formation (Tiganos et
al., 1997; Klimkait et al., 1990; Schubert et al., 1998;
McCormick-Davis et al., 2000). Previous studies have
shown that phosphorylation of two serine residues is
essential for the CD4 down-regulation caused by Vpu
(Paul and Jabbar, 1997). Because CD4 can also be down-© 2002 Elsevier Science (USA)
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252regulated from the infected cell surface by Env and Nef,
it has been suggested that Vpu may be dispensable for
the disease in humans (Piguet et al., 1999). Enhancement
of virion release from infected cells by Vpu has been
associated with the transmembrane domain and the abil-
ity of this protein to form ion channels that are weakly
selective for cations (Schubert et al., 1996; Sansom et al.,
1998). Currently, the mechanism by which Vpu enhances
virion release is unknown.
Previous studies have shown that the Vpu and Env pro-
teins are translated from different reading frames from the
same messenger RNA (mRNA) species, with translation of
the Env protein starting 163 nucleotides downstream from
the initiation codon for Vpu (D’Agostino et al., 1992). Be-
cause of the unique structure of this late mRNA, it suggests
that the upstream Vpu sequences prior to the env may
attenuate the expression of the Env protein. Whether com-
plete deletion of these upstream sequences would result in
a more virulent or attenuated phenotype is not currently
known. With the availability of pathogenic simian–human
immunodeficiency viruses (SHIV) that cause massive loss
of circulating CD4 T cells in rhesus and pig-tailed ma-
caques (Reiman et al., 1996; Shibata et al., 1997; Liu et al.,
1999; Luciw et al., 1999; McCormick-Davis et al., 2000), itresults of these studies indicate that the Vpu coding seque
biosynthesis but significantly contribute to the pathogenes
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should be possible to better understand the role of Vpu in
a nonhuman primate model system. In order to determinences u
is of th
on
whether the vpu sequences prior to env can attenuate the
amount of HIV-1 Env biosynthesis and remain pathogenic
for macaques, we constructed a SHIV in which the entire
vpu sequence prior to the beginning of env was removed.
Our results suggest that removal of the vpu sequences
upstream of env resulted in enhanced Env precursor syn-
thesis but that the virus has a low pathogenic phenotype for
pig-tailed macaques, even though low levels of replicating
virus were detected in lymphoid tissues over 1 year after
inoculation.
RESULTS
The novpuSHIVKU-1bMC33 synthesizes more Env
precursor than parental SHIVKU-1bMC33
Pulse–chase analysis was used to examine the kinet-
ics of viral Gag and Env biosynthesis and subsequent
release of viral proteins from infected cells. The results
of these experiments are shown in Fig. 1. Using the Gag
precursor (p57) as the baseline for comparison as it was
identical in both viruses, the amount of Env precursor
(gp160) synthesized in novpuSHIVKU-1bMC33-inoculated cul-
tures was clearly enhanced when compared to
SHIVKU-1bMC33-inoculated cultures (Figs. 1A and 1C). Den-
sitometric analysis confirmed that the amount of gp160
was enhanced compared to p57 (Fig. 2). While the
amount of gp160 synthesized and processed within the
cell was enhanced, the kinetics of gp120 and p27 cleav-
age from Gag and Env precursor proteins was similar in
C8166 cultures inoculated with either virus. Further, the
release of p27 into the culture medium was clearly de-
layed (Figs. 1B and 1D), which was due to the deletion of
the vpu and is similar to what we had reported earlier for
vpuSHIVKU-1bMC33 (McCormick-Davis et al., 2000). To de-
termine whether Vpu-mediated virion release could be
restored by supplying Vpu in trans, a complementation
assay was performed by coinfecting novpuSHIVKU-1bMC33-
inoculated cultures with a recombinant vaccinia virus
expressing Vpu prior to pulse–chase analysis. The re-
sults indicated that expression of Vpu in trans restored
the kinetics of virion release to that seen in parental
SHIVKU-1bMC33 (Fig. 3). We also examined the time at which
FIG. 1. Pulse–chase analysis of gp120 and p27 in C8166 cultures inoculated with SHIVKU-1bMC33 and novpuSHIVKU-1bMC33. Cultures of C8166 cells were
inoculated with SHIVKU-1bMC33 or novpuSHIVKU-1bMC33 as described under Materials and Methods. At 4 days postinfection, infected cells were starved for
methionine for 2 h and then pulse labeled with 1 mCi of [35S]methionine/cysteine for 1 h. The medium containing the radiolabel was removed and
washed once with medium containing 100 cold methionine and cysteine, and the radiolabel was chased in the same medium for various periods
of time (0, 1, 2, 4, and 6 h). The culture medium was collected and cell lysates were prepared as described in the text. SHIV-specific proteins were
immune precipitated using a pooled serum from four macaques that had been infected with SHIVKU-1 for 6 months (McCormick-Davis et al., 2000).
SHIV-specific proteins from the cell lysates and culture medium from SHIVKU-1bMC33-inoculated C8166 cultures are shown in A and C, respectively.
SHIV-specific proteins from the cell lysates and culture medium from novpuSHIVKU-1bMC33-inoculated C8166 cultures are shown in B and D, respectively.
Uninfected C8166 cells, radiolabeled and chased for 6 h, served as a negative control (lanes C). All samples were analyzed under reducing conditions
by SDS–PAGE (9% gel) and visualized by standard autoradiographic techniques.
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syncytia formation occurred in C8166 cultures following
inoculation with equivalent amounts of SHIVKU-1bMC33 or
novpuSHIVKU-1bMC33. We did not observe a significant in-
crease in the rate of syncytia formation in cultures inoc-
ulated with SHIVKU-1bMC33 or novpuSHIVKU-1bMC33 (data not
shown).
Inoculation of cells with novpuSHIVKU-1bMC33 or
SHIVKU-1bMC33 produces similar amounts of env mRNA
in C8166 cultures
To determine whether the observed increase in Env
synthesis in novpuSHIVKU-1bMC33 inoculated cultures was
due to aberrant levels of env mRNA, C8166 cells were
inoculated with the same number of infectious units of
SHIVKU-1bMC33 or novpuSHIVKU-1bMC33 and at 5 days, total
RNA was extracted and subjected to Northern blot anal-
ysis using a vpu/gp120 probe. As shown in Fig. 4, similar
amounts of 9- and 4-kb RNA species were detected,
suggesting that the observed increase in Env biosynthe-
sis was not due to aberrant splicing.
novpuSHIVKU-1bMC33 inoculated pig-tailed macaques
show no significant CD4 T cell loss and virus could
not be recovered past 27 weeks after inoculation
We determined whether novpuSHIVKU-1bMC33 was
capable of causing the same CD4 T cell loss that is
observed following inoculation with the parental
SHIVKU-1bMC33. Neither of the pig-tailed macaques inocu-
lated with novpuSHIVKU-1bMC33 developed a significant loss
of CD4 T cells and at necropsy (56 weeks) the circulat-
ing CD4 T cell levels were 735 cells/l for macaque
AD7B and 1251 cells/l for AT4V (Fig. 5A). In contrast, the
two macaques inoculated with SHIVKU-1bMC33 (macaques
2000 and 2001) both developed a severe loss of CD4 T
cells within 1 month of inoculation and the low levels of
circulating CD4 T cells were maintained throughout the
course of their 28-week period of study (Fig. 5B). We also
examined the virus loads in these macaques inoculated
with novpuSHIVKU-1bMC33 using infectious center assays
(Fig. 5C). Similar to other SHIV infections (both patho-
genic and nonpathogenic), large numbers of peripheral
blood mononuclear cells (PBMCs) producing infectious
cytopathic virus could be recovered early after inocula-
tion but the numbers of cells producing virus gradually
diminished and virus could not be recovered from these
macaques after 27 weeks, although the PBMCs were still
positive for viral gag using nested PCR (data not shown).
At necropsy, no virus could be recovered by coculturing
cells from the spleen, lymph node, or thymus from ma-
FIG. 2. Densiometric comparison of Env precursor (gp160) and Gag
levels at the 0 time chase period from the pulse–chase analysis of
cultures inoculated with SHIVKU-1bMC33 or novpuSHIVKU-1bMC33 in Fig. 1.
*Values within 0.01 of each other.
FIG. 3. Complementation of Vpu in trans restores virion release from
novpuSHIVKU-1bMC33-inoculated cultures. Cultures of C8166 cells were
inoculated with novpuSHIVKU-1bMC33 and at 5 days postinoculation, cul-
tures were divided in half and reinoculated with a recombinant vaccinia
virus expressing Vpu or wild-type vaccinia. Three hours after inocula-
tion with vvVpu or wtVV, cells were starved for methionine and analyzed
by pulse–chase analysis, and SHIV proteins were immune precipitated
from the culture medium as described under Materials and Methods.
SHIV-specific proteins from the cell culture medium from novpuSHIVKU-
1bMC33-inoculated cultures coinfected with wtVV or vvVpu are shown in A
and B, respectively. Uninfected C8166 cells, radiolabeled and chased
for 6 h served as a negative control (lanes C). All samples were
analyzed under reducing conditions by SDS–PAGE (9% gel) and visu-
alized by standard autoradiographic techniques.
FIG. 4. Northern blot analysis of SHIV RNA in C8166 cells inoculated
with novpuSHIVKU-1bMC33 or SHIVKU-1bMC33. C8166 cells were infected with
equivalents amounts of virus (0.01 m.o.i.) and at 5 days, total RNA was
extracted from cultures. A total of 20 g of total cellular RNA was
loaded per lane and hybridized with a 32P-labeled gp120 probe. Lane 1,
novpuSHIVKU-1bMC33-inoculated C8166 cells. Lane 2, SHIVKU-1bMC33-inocu-
lated C8166 cells. Lane 3, uninoculated C6166 cells.
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caque AT4V with C8166 cells. Low levels of cells produc-
ing infectious cytopathic virus were recovered from the
lymph node (10 per 106 cells) upon coculturing with
C8166 cells, and cells producing infectious, cytopathic
virus were also recovered from spleen cells from ma-
caque AD7B.
Replicating virus was detected in the lymphoid
organs from novpuSHIVKU-1bMC33-inoculated macaques
In addition to infectious center assays, we examined
total DNA extracted from visceral organs using nested
PCR tests to determine whether: (a) the viral genome
was present (presence of gag sequences) and (b) repli-
cating virus could be detected as determined by the
presence of 2-long terminal repeat (2-LTR) circles. As
shown in Fig. 6A, we were able to detect gag sequences
in the liver, small intestine, lymph node, spleen, and
thymus tissues from AD7B but were unable to detect
viral sequences in the lung and kidney tissues. Similarly,
gag sequences were detected in the lymph node, spleen,
and thymus tissue DNA samples from AT4V but not from
the kidney, liver, and lung tissue DNA samples (Fig. 6B).
Examination of the same samples for the presence of
2-LTR circles revealed their presence in the lymph node,
spleen, and thymus tissues from both macaques (Figs.
7A and 7B). Thus, while infectious, cytopathic virus was
not recovered after week 27 and the circulating CD4 T
cells were in the normal range, low levels of virus repli-
cation were detected in the lymphoid tissues of these
two macaques.
The central nervous system did not serve as a
reservoir for actively replicating novpuSHIVKU-1bMC33
In addition to the visceral organs, we examined 13
regions of the central nervous system (CNS) for the
presence of virus (presence of gag sequences) and
replicating virus (presence of 2-LTR sequences). As
shown in Figs. 6C and 6D, we were able to detect vpu
sequences in only 1 of 13 regions examined from
AD7B and no regions examined from AT4V. When the
same samples were examined for the presence of
2-LTR circles, none of the regions positive for gag
sequences were positive for 2-LTR circles (data not
shown). These results indicate that virus was largely
absent in the CNS of both macaques (only 1 of 26
regions examined) and that actively replicating virus
was not detected.
Histological analysis revealed that one of the two
novpuSHIVKU-1bMC33-inoculated macaques showed
severe atrophy of the thymus
Histological examination of the visceral organs (lymph
nodes, spleen, thymus, kidney, liver, lung, and small
intestine) from the two macaques inoculated with nov-
puSHIVKU-1bMC33 revealed that macaque AT4V had no his-
tological lesions. Examination of the same tissues from
macaque AD7B revealed that all tissues with the excep-
tion of the thymus had no significant histological lesions.
The thymus from this macaque, however, had undergone
severe atrophy that was characterized by collapse of the
thymic lobular architecture, a massive decrease in the
number of thymocytes, and an increase in the amount of
connective tissue (Fig. 8). Neither macaque had histo-
logical lesions in the CNS as determined by staining of
sections with hematoxylin and eosin.
DISCUSSION
The Vpu and Env proteins of HIV-1 (and SHIV) are
translated from different reading frames off the same
biscistronic mRNA late in the infection cycle (Schwartz et
al., 1990). It is known that the presence of upstream open
reading frames (uORF) can have a profound influence on
FIG. 5. (A) The levels of circulating CD4 T cells in macaques AD7B
() and AT4V (F) following inoculation with novpuSHIVKU-1bMC33. (B) The
levels of circulating CD4 T cells in macaques 2000 () and 2001 (F)
following inoculation with SHIVKU-1bMC33. (C) The numbers of PBMC
producing infectious, cytopathic virus in macaques AD7B () and AT4V
(F) following inoculation with novpuSHIVKU-1bMC33.
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the initiation of translation at downstream AUGs (Morris
and Geballe, 2000). Since the AUG codon for vpu is a
poor match for the Kozak consensus A/GCCAATGG, pre-
sumably a proportion of the scanning complexes may fail
to initiate at the vpu AUG and continue scanning (i.e.,
leaky scanning) to the initiation AUG at the beginning of
the env gene. Thus, because of the proximity to the env
gene, we believe that vpu represents an uORF in that it
could potentially regulate the levels of Env precursor
synthesized by reducing the initiation of translation from
the env AUG. To test this hypothesis, we constructed a
SHIV in which the vpu sequences preceding the env
were completely eliminated and analyzed the biosynthe-
sis of viral proteins in infected cultures using pulse–
chase experiments. The results of our pulse–chase stud-
ies indicate that more Env precursor was synthesized in
cells infected with the novpuSHIVKU-1bMC33 compared to
the parental SHIVKU-1bMC33. While there was enhanced
biosynthesis of the Env precursor, enhanced release of
gp120 cleavage product from infected cells was not ob-
served, presumably because of the lack of a functional
Vpu protein, which has previously been shown to en-
hance HIV-1 and SHIV release from infected cells (Klim-
kait et al., 1990; McCormick-Davis et al., 2000). The
results presented here are in agreement with previous
studies which examined vpu and vpu strains of HIV-1
for the ability to induce syncytial cytopathology (Yao et
al., 1993). One important difference is that in that study,
the vpuvirus analyzed had a point mutation rather than
deletion of all of the upstream Vpu sequences prior to
env. The results of that study also concluded that Vpu
contributed to the cytopathic nature of the virus. These
FIG. 6. PCR analysis of macaque AD7B and AT4V tissue DNA preparations for SHIV sequences. DNA was extracted from 6 to 7 visceral organs
and 13 regions of the CNS and used in nested PCR using oligonucleotide primers specific for amplification of the SIV gag gene as described in the
text. Ten microliters of the reaction products was run in a 1.5% agarose gel and stained with ethidium bromide. (A) Agarose gel showing the presence
of gag sequences from 7 visceral organs of AD7B. (B) Agarose gel showing the presence of gag sequences from 6 visceral organs of AT4V. (C)
Agarose gel showing the presence of gag sequences in one of 13 regions of the CNS from AD7B. (D) Agarose gel showing the absence of gag
sequences in 13 regions of the CNS from macaque AT4V. Order of samples on gel in A: Lane 1, kidney. Lane 2, liver. Lane 3, lung. Lane 4, small
intestine. Lane 5, mesenteric lymph node. Lane 6, spleen. Lane 7, thymus. Lane 8, negative control. Lane 9, positive control. Lane 10, molecular weight
markers. Order of samples on gel in B: Lane 1, kidney. Lane 2, liver. Lane 3, lung. Lane 4, mesenteric lymph node. Lane 5, spleen. Lane 6, thymus.
Lane 7, positive control. Lane 8, negative control. Lane 9, molecular weight markers. Order of samples on gel in C: Lane 1, frontal cortex. Lane 2, motor
cortex. Lane 3, parietal cortex. Lane 4, occipital cortex. Lane 5, temporal cortex. Lane 6, basal ganglia. Lane 7, midbrain. Lane 8, pons. Lane 9, medulla.
Lane 10, cerebellum. Lane 11, cervical spinal cord. Lane 12, thoracic spinal cord. Lane 13, lumbar spinal cord. Lane 14, positive control. Lane 15,
negative control. Lane 16, molecular weight markers. Order of samples on gel in D is the same as in C except that the negative and positive controls
were reversed.
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results suggest that the vpu in fact attenuates the
amount of Env protein that is synthesized in cells.
Since only HIV-1 and SIVcpz encode a Vpu protein, we
have employed the pathogenic SHIV/pig-tailed macaque
model to assess the effects of the Vpu protein on patho-
genesis (Joag et al., 1996; Stephens et al., 1997; McCor-
mick-Davis et al., 2000). Previously we had shown that
another SHIV derived from SHIVKU-1bMC33, which had over
50% of the coding sequences of vpu deleted
(vpuSHIVKU-1bMC33), caused neuroAIDS in one of four ma-
caques inoculated (McCormick-Davis et al., 2000; Singh
et al., 2001). Further examination of the virus from the
macaque that developed neuroAIDS revealed that selec-
tion of additional mutations in Env and Nef probably
compensated for the lack of a functional Vpu (Singh et al.,
2001). However, unlike the novpuSHIVKU-1bMC33, Env pre-
cursor biosynthesis in vpuSHIVKU-1bMC33-infected cells
was similar to the parental SHIVKU-1bMC33 (McCormick-
Davis et al., 2000). To determine whether the enhanced
Env precursor biosynthesis had an effect on the patho-
genesis of this SHIV, two pig-tailed macaques were in-
oculated with this virus. Our findings indicated that no
vpuSHIVKU-1bMC33 did not result in a significant loss of
circulating CD4 T cells over the 56-week study period,
although one macaque developed severe atrophy of
the thymus which is not observed in uninfected ma-
caques of this age, suggesting that complete deletion
of the vpu did not completely attenuate this virus. In
addition, while we were not able to recover infectious
cytopathic virus from the circulating PBMCs past 27
weeks postinoculation, we were able to demonstrate
the presence of 2-LTR circles in several lymphoid
FIG. 7. PCR analysis of visceral organ tissue DNA preparations from
macaques AT4V (A) and AD7B (B) for 2-LTR sequences. DNA was
extracted from various organs and used in nested PCR using the
appropriate oligonucleotide primers as described in the text. Ten mi-
croliters of the reaction products was run in a 1.5% agarose gel and
stained with ethidium bromide. Order of samples on gel in A: Lane 1,
kidney. Lane 2, liver. Lane 3, lung. Lane 4, mesenteric lymph node. Lane
5, spleen. Lane 6, thymus. Lane 7, negative control. Lane 8, positive
control. Lane 9, molecular weight markers. Order of samples on gel in
B: Lane 1, kidney. Lane 2, liver. Lane 3, lung. Lane 4, small intestine.
Lane 5, mesenteric lymph node. Lane 6, spleen. Lane 7, thymus. Lane
8, negative control. Lane 9, positive control. Lane 10, molecular weight
markers.
FIG. 8. Histological examination reveals severe atrophy in the thymus in macaque AT4V. (A–C) Hematoxylin and eosin stain of the thymus from AT4V
showing normal-appearing thymus. (D–F) Hematoxylin and eosin stain of the thymus from macaque AD7B showing massive depletion of thymocytes,
collapse of thymic lobular architecture, and increased connective tissue. Scale bars, 250 m.
257ENHANCED Env SYNTHESIS BY A Vpu DELETION MUTANT
organs (spleen, lymph nodes, thymus) from these ma-
caques at necropsy (Fig. 5). Why replicating virus in
the thymus was associated with severe atrophy in
macaque AD7B but not AT4V is unknown at this time.
It is possible that viral variants had been selected for
in this tissue that were associated with the observed
atrophy. Nevertheless, these results indicate that virus
was probably replicating at low levels in the lymphoid
tissues and was associated with histological lesions
in selected lymphoid tissues. Other investigators have
found that administration of gene-deleted, attenuated
SHIV viruses will protect against challenge with viru-
lent SHIVs (Haga et al., 1998; Joag et al., 1998; Ui et al.,
1999; Yoshino et al., 2000; Silverstein et al., 2000) and
some investigators have suggested that the long-term
virus burden gradually decreases with time (Silver-
stein et al., 2000). However, the use of more sensitive
nested PCR techniques that detect 2-LTR circles and
demonstrate the presence of active virus replication
were not employed in these studies. Similar to our
observations with this attenuated SHIV, others have
shown that lymphoid tissues are a major reservoir for
HIV-1 following highly active antiretroviral therapy
(Haase, 1999; Chun and Fauci, 1999; Chun et al., 2000)
and suggest that live, attenuated SHIV vaccines will
face similar hurdles in eliminating the small but pro-
ductively infected pool of lymphoid cells.
Previous studies with attenuated SIV and SHIV have
not critically examined different regions of the CNS for
the presence of virus by sensitive PCR techniques. It is
generally accepted that HIV, SIV, and SHIV traffic to the
CNS early after infection and thus could be a potential
reservoir for new virus variants that evolve over the
course of the disease (Price et al., 1988; Smith et al.,
1994; Raghavan et al., 1997; Haase, 1999). Therefore, we
examined whether an attenuated virus such as nov-
puSHIVKU-1bMC33 was neuroinvasive and if low levels of
virus replication occurred in the CNS as they did in the
lymphoid tissues. Our results indicate that active virus
replication of the attenuated novpuSHIVKU-1bMC33 was not
occurring at the time of necropsy. Thus, while this virus
was not completely innocuous (as demonstrated by the
severe thymus atrophy in macaque AD7B and low-level
viral replication in lymphoid tissues), these results indi-
cate that the CNS was not a significant reservoir for
novpuSHIVKU-1bMC33.
MATERIALS AND METHODS
Cells, plasmids, and viruses
The lymphocyte C8166 cell line was used as the indi-
cator cells to measure infectivity and cytopathicity of the
viruses used in this study. C8166 cells were maintained
in RPMI 1640, supplemented with 10 mM HEPES buffer,
pH 7.3, 2 mM glutamine, 5 g/ml gentamicin, and 10%
fetal bovine serum (R10FBS). The derivation of
SHIVKU-1bMC33 has been previously described (McCormick-
Davis et al., 2000).
Construction of the novpuSHIVKU-1bMC33
The virus without vpu sequences 5 to the env was
constructed using the molecularly cloned SHIVKU-1bMC33
genome, which is a pathogenic derivative of SHIV-4 ca-
pable of causing severe CD4 T cell loss and AIDS in
pig-tailed macaques (Narayan et al., 1999). This was
accomplished by subcloning the SphI/KpnI fragment
from p3SHIVKU-1bMC33, containing the tat, rev, and vpu
sequences from SHIVKU-1bMC33 into the SphI and KpnI sites
of plasmid pUC19 in which the SspI site was removed.
This plasmid, ptrvSHIVKU-1bMC33, was used to introduce a
unique NsiI site at the AUG of vpu using the Quick Change
Site Directed Mutagenesis kit (Stratagene) with the primer
5-GCAGTAAGTAGTACATGTAATGCATCCTATACCAATAGTA-
GCAATAG-3 and its complement 5-CTATTGCTACTATTG-
GTATAGGATGCATTACATGTACTACTTACTGC-3 according
to the manufacturer’s directions. The resulting plasmid was
digested with NsiI and BbsI to release a 155-bp fragment,
treated with Klenow, and ligated. The ligated product was
used to transform Escherichia coli (strain XL-1 Blue) and a
plasmid was selected for the absence of an NsiI site. This
plasmid was digested with SphI and KpnI, purified by elec-
trophoresis in a 1% agarose gel, and extracted through a
Millipore column. The 380-bp fragment was ligated into
p3SHIVKU-1bMC33, which was also digested with SphI and
KpnI to release a 535-bp fragment. The ligated product was
used to transform E. coli (strain XL-1 Blue) and plasmids
were selected for a 380-bp fragment when digested with
SphI and KpnI. In the resulting plasmid, p3novpuSHIVKU-
1bMC33, 155 bp of vpu prior to env was deleted without dis-
rupting the initiation AUG of env (Fig. 9). For generation of
SHIVKU-1bMC33 virus, p5SHIV-4 and p3novpuSHIVKU-1bMC33
plasmids (containing tat, rev, env, and nef genes from
SHIVKU-1b) were digested to completion with SphI, ligated
using T4 DNA ligase, and transfected into C8166 cells using
the DEAE–dextran method as previously described (Mill-
man and Herzberg, 1981). Infectious virus was titrated in
C8166 cells as previously described (Joag et al., 1996).
Pulse–chase analysis of viral proteins
To determine whether viral structural proteins were
released with reduced efficiency in novpuSHIVKU-1bMC33-
inoculated cultures, C8166 cells were inoculated with 103
TCID50 of either novpuSHIVKU-1bMC33 or SHIVKU-1bMC33. At 5
days postinfection, the medium was removed and in-
fected cells were incubated in methionine/cysteine-free
Dulbecco’s modified Eagle’s medium (DMEM) for 2 h.
The cells were then radiolabeled for 30 min with 1
mCi/ml of 35S-Translabel (methionine and cysteine, ICN
Biomedical, Costa Mesa, CA) and the radiolabel was
chased for various periods of time in DMEM containing
100 unlabeled methionine/cysteine. SHIV proteins
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were immune precipitated from the cell culture medium
and infected cell lysates using plasma pooled from sev-
eral rhesus monkeys infected previously with SHIVKU-1.
Briefly, the cell culture medium was clarified (16,000 g)
for 2 min. The supernatant was transferred and made 1
with respect to cell lysis buffer (50 mM Tris–HCl, pH 7.5;
50 mM NaCl; 0.5% deoxycholate; 0.2% SDS; 10 mM
EDTA) and SHIV proteins were immune precipitated with
10 l of a pooled serum from several monkeys that were
inoculated with nonpathogenic SHIV for over 1 year. For
immune precipitation of cell-associated SHIV proteins,
cell lysates were prepared as described previously (Ste-
phens et al., 1995, 1997; McCormick-Davis et al., 2000)
prior to incubation with antiserum. Lysates were centri-
fuged in a microfuge to remove nuclei prior to the addi-
tion of antibody. Cell lysates and culture medium were
incubated with antibody for 16 h at 4°C. All immune
precipitates were collected on protein A–Sepharose, the
beads were washed three times with RIPA buffer, and the
samples were resuspended in sample reducing buffer.
Samples were boiled and the SHIV-specific proteins
were analyzed by SDS–PAGE. Proteins were then visu-
alized by standard autoradiographic techniques.
To determine whether Vpu supplied in trans would
restore enhanced virion release, C8166 cells were first
inoculated with novpuSHIVKU-1bMC33 as described above.
At 5 days postinoculation, cells were coinfected with a
recombinant vaccinia virus expressing Vpu (vvVpu)
(Kerkau et al., 1997). At 4 h postinoculation with vvVpu,
inoculated cultures were subjected to pulse–chase ex-
periments as described above.
Viral RNA analysis by Northern blot hybridization
Total cellular RNA was isolated with Trizol (Gibco BRL)
as specified by the manufacturer’s protocols, samples
were standardized by their optical density at 262 nm, and
20 g of RNA per lane was resolved by electrophoresis
through an agarose–formaldehyde gel [1% agarose, 2.2
M formaldehyde, 10% (vol/vol) 10 MOPS (0.4 M MOPS,
pH 7.0, 0.1 M sodium acetate, 0.01 EDTA)] in 1 MOPS
buffer. The gels were denatured in 0.05 M NaOH–1.5 M
NaCl for 30 min, neutralized in 0.5 Tris–HCl (pH 7.4) to 1.5
M NaCl for 20 min, and washed in 20 SSC for 45 min,
and RNA was blotted onto a 0.45-m-pore-size Nytran
SPC membrane (Schleicher and Schuell, Keene, NH) and
hybridized with a 1.5-kb (gp120) fragment labeled with
[-32P]dCTP using the Random Prime DNA Labeling Sys-
tem (Gibco BRL). Hybridization was carried out overnight
in 42°C in a buffer containing 6 SSC, 5 Denhardt’s
reagent, 0.5% SDS, 100 g of salmon sperm DNA per
milliliter, and 50% formamide. The membranes were
washed under stringent conditions and analyzed by au-
toradiography.
Macaques analyzed in this study
Two pig-tailed macaques (AD7B and AT4V) were inoc-
ulated intravenously with 1 ml of undiluted supernatant
from C8166-grown stocks of novpuSHIVKU-1bMC33 contain-
ing approximately 104 TCID50 per milliliter as previously
described (McCormick-Davis et al., 2000). These ma-
caques were euthanized in good condition at 56 weeks
following inoculation. Two additional macaques (2000
and 2001) were inoculated with pathogenic SHIVKU-1bMC33
and developed significant loss of CD4 T cells over the
course of the 6-month study period. The animals were
housed in the AAALAC-approved animal facility at the
University of Kansas Medical Center. Heparinized blood
was collected weekly for 4 weeks, then at 2-week inter-
vals for the next month, and thereafter at monthly inter-
vals.
Processing of blood and tissue samples
The PBMCs were prepared by centrifugation on Ficoll–
Hypaque gradients as described previously (Joag et al.,
1996). Tenfold dilutions of PBMCs (106 cells/ml) were
inoculated into replicate cultures of C8166 cells in 24-
well plates and the cocultures were examined for devel-
opment of cytopathic effects as previously described
(McCormick-Davis et al., 2000). Infectivity titers in plasma
were reported as TCID50/ml and cells producing infec-
tious cytopathic virus in the blood were reported as the
number of infected cells/106 PBMCs. Alterations in CD4
and CD8 T lymphocytes after experimental inoculations
were monitored sequentially by FACS analysis (Becton
Dickinson). T lymphocyte subsets were labeled with
OKT4 (CD4; Ortho Diagnostics Systems, Inc.), B9.11 (CD8,
Coulter Immunology), and SP34 (CD3; Pharmingen) or
FN18 (CD3; Biosource International) monoclonal anti-
bodies.
FIG. 9. The sequence of the vpu/env region in the parental SHIVKU-1bMC33 and novpuSHIVKU-1bMC33 viruses.
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Detection of viral sequences in inoculated macaques
gag gene. The amplification of the gag gene from
tissue DNAs was performed according to previously de-
scribed procedures (Joag et al., 1994; Stephens et al.,
1998).
Long terminal repeat circles. Examination of 2-LTR
circular DNA provides a view of a spreading infection
based on a viral DNA form that is structurally distinct and
known to have a short half-life in infected cells (Pauza et
al., 1994; Zazzi et al., 1997; Teo et al., 1997; Panther et al.,
1998; Sharkey et al., 2000; Sharkey and Stevenson, 2001).
We analyzed the DNA isolated from PBMC, ileum, liver,
lymph node, lung, and spleen and the 13 regions of the
CNS for the presence of 2-LTR circular forms of DNA as
previously described (McCormick-Davis et al., 2000). The
oligonucleotides used in the first round were 5-ATT-
TCGCTCTGTATTCAGTCGCTCTGC-3 (U5 region) and 5-
CCTCCTGTGCCTCATCTGATACATTTAC-3 (U3 region),
which correspond to bases 10,335 to 10,361 and 180 to
153 of the SHIV genome, respectively. The PCR amplifi-
cation was performed using the following conditions:
denaturation at 92°C for 1 min, annealing at 55°C for 1
min, and primer extension at 72°C for 3 min. One micro-
liter of the first PCR product was used as a template for
a second amplification using the same conditions. The
oligonucleotide primers used for the second round were
5-AGGTTCTCTCCAGCACTAGCAGGTAGAGC-3 (U5 re-
gion) and 5-TTGGGTATCTAATTCCTGGTCCTGAG-3
(U3 region; opposite strand; 456), which correspond to
bases 10,389 to 10,417 and 120 to 95 of the SHIV
genome, respectively. Samples were amplified for an-
other 35 cycles as described above. Following the
second round of amplification, a 10-l aliquot was
removed and run on a 1.5% agarose gel, and bands
were visualized by staining with ethidium bromide.
The predicted product of the 2-LTR PCR product is 361
basepairs.
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